AU2014202705B2 - Grouped leads for spinal stimulation - Google Patents

Grouped leads for spinal stimulation Download PDF

Info

Publication number
AU2014202705B2
AU2014202705B2 AU2014202705A AU2014202705A AU2014202705B2 AU 2014202705 B2 AU2014202705 B2 AU 2014202705B2 AU 2014202705 A AU2014202705 A AU 2014202705A AU 2014202705 A AU2014202705 A AU 2014202705A AU 2014202705 B2 AU2014202705 B2 AU 2014202705B2
Authority
AU
Australia
Prior art keywords
electrode
lead
dorsal root
electrodes
root ganglion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014202705A
Other versions
AU2014202705A1 (en
Inventor
Mir A. Imran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spinal Modulation LLC
Original Assignee
Spinal Modulation LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US60/873,464 priority Critical
Priority to AU2012203467A priority patent/AU2012203467B2/en
Application filed by Spinal Modulation LLC filed Critical Spinal Modulation LLC
Priority to AU2014202705A priority patent/AU2014202705B2/en
Publication of AU2014202705A1 publication Critical patent/AU2014202705A1/en
Application granted granted Critical
Publication of AU2014202705B2 publication Critical patent/AU2014202705B2/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

Abstract

A lead for stimulating nerve anatomy comprising an elongate body having at least one first electrode disposed thereon and at least one second electrode longitudinally aligned a longitudinal distance from the at least one first electrode, wherein the longitudinal distance provides for the at least one first electrode to be positioned on, near or about a dorsal root ganglion so as to provide selective stimulation thereto while the at least one second electrode is positioned outside of a spinal nerve root associated with the dorsal root ganglion.

Description

GROUPED LEADS FOR SPINAL STIMULATION CROSS-REFERENCES TO RELATED APPLICATIONS [0001] This application claims priority of provisional patent application no. 60/873,464 5 (Attorney Docket No. 10088-706.101), filed on December 6, 2006, which is incorporated herein by reference for all purposes. STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT [0002] NOT APPLICABLE 10 REFERENCE TO A "SEQUENCE LISTING," A TABLE, OR A COMPUTER PROGRAM LISTING APPENDIX SUBMITTED ON A COMPACT DISK. [0003] NOT APPLICABLE 15 BACKGROUND OF THE INVENTION [0004] The application of specific electrical energy to the spinal cord for the purpose of managing pain has been actively practiced since the 1 9 60s. It is known that application of an electrical field to spinal nervous tissue can effectively mask certain types of pain transmitted from regions of the body associated with the stimulated nervous tissue. Such masking is 20 known as paresthesia, a subjective sensation of numbness or tingling in the afflicted bodily regions. Application of electrical energy has been based on the gate control theory of pain. Published in 1965 by Melzack and Wall, this theory states that reception of large nerve fiber information, such as touch, sense of cold, or vibration, would turn off or close the gate to reception of painful small nerve fiber information. The expected end result would, therefore, 25 be pain relief. Based on the gate control theory, electrical stimulation of large fibers of the spinal cord cause small fiber information to be reduced or eliminated at that spinal segment and all other information downstream from that segment would be reduced or eliminated as well. Such electrical stimulation of the spinal cord, once known as dorsal column stimulation, is now referred to as spinal cord stimulation or SCS. 30 [00051 Figs. lA-lB illustrate conventional placement of an SCS system 10. Conventional SCS systems include an implantable power source or implantable pulse generator (IPG) 12 1 and an implantable lead 14. Such IPGs 12 are similar in size and weight to pacemakers and are typically implanted in the buttocks of a patient P. Using fluoroscopy, the lead 14 is implanted into the epidural space E of the spinal column and positioned against the dura layer D of the spinal cord S, as illustrated in Fig. 1B. The lead 14 is implanted either through the 5 skin via an epidural needle (for percutaneous leads) or directly and surgically through a mini laminotomy operation (for paddle leads). 10006] Fig. 2 illustrates example conventional paddle leads 16 and percutaneous leads 18. Paddle leads 16 typically have the form of a slab of silicon rubber having one or more electrodes 20 on its surface. Example dimensions of a paddle lead 16 is illustrated in Fig. 3. 10 Percutaneous leads 18 typically have the form of a tube or rod having one or more electrodes 20 extending therearound. Example dimensions of a percutaneous lead 18 is illustrated in Fig. 4. [00071 Implantation of a percutaneous lead 18 typically involves an incision over the low back area (for control of back and leg pain) or over the upper back and neck area (for pain in 15 the arms). An epidural needle is placed through the incision into the epidural space and the lead is advanced and steered over the spinal cord until it reaches the area of the spinal cord that, when electrically stimulated, produces a comfortable tingling sensation (paresthesia) that covers the patient's painful area. To locate this area, the lead is moved and turned on and off while the patient provides feedback about stimulation coverage. Because the patient 20 participates in this operation and directs the operator to the correct area of the spinal cord, the procedure is performed with local anesthesia. [0008] Implantation of paddle leads 16 typically involves performing a mini laminotomy to implant the lead. An incision is made either slightly below or above the spinal cord segment to be stimulated. The epidural space is entered directly through the hole in the bone and a 25 paddle lead 16 is placed over the area to stimulate the spinal cord. The target area for stimulation usually has been located before this procedure during a spinal cord stimulation trial with percutaneous leads 18. [0009] Although such SCS systems have effectively relieved pain in some patients, these systems have a number of drawbacks. To begin, as illustrated in Fig. 5, the lead 14 is 30 positioned upon the spinal cord dura layer D so that the electrodes 20 stimulate a wide portion of the spinal cord and associated spinal nervous tissue. The spinal cord is a continuous body and three spinal levels of the spinal cord are illustrated. For purposes of 2 illustration, spinal levels are sub-sections of the spinal cord S depicting that portion where the dorsal root DR and ventral root VR join the spinal cord S. The peripheral nerve N divides into the dorsal root DR and the dorsal root ganglion DRG and the ventral nerve root VR each of which feed into the spinal cord S. An ascending pathway 17 is illustrated between level 2 5 and level 1 and a descending pathway 19 is illustrated from level 2 to level 3. Spinal levels can correspond to the veterbral levels of the spine commonly used to describe the vertebral bodies of the spine. For simplicity, each level illustrates the nerves of only one side and a normal anatomical configuration would have similar nerves illustrated in the side of the spinal cord directly adjacent the lead. 10 [00101 Motor spinal nervous tissue, or nervous tissue from ventral nerve roots, transmits muscle/motor control signals. Sensory spinal nervous tissue, or nervous tissue from dorsal nerve roots, transmit pain signals. Corresponding dorsal and ventral nerve roots depart the spinal cord "separately"; however, immediately thereafter, the nervous tissue of the dorsal and ventral nerve roots are mixed, or intertwined. Accordingly, electrical stimulation by the 15 lead 14 often causes undesirable stimulation of the motor nerves in addition to the sensory spinal nervous tissue. [0011] Because the electrodes span several levels the generated stimulation energy 15 stimulates or is applied to more than one type of nerve tissue on more than one level. Moreover, these and other conventional, non-specific stimulation systems also apply 20 stimulation energy to the spinal cord and to other neural tissue beyond the intended stimulation targets. As used herein, non-specific stimulation refers to the fact that the stimulation energy is provided to all spinal levels including the nerves and the spinal cord generally and indiscriminately. Even if the epidural electrode is reduced in size to simply stimulate only one level, that electrode will apply stimulation energy indiscriminately to 25 everything (i.e. all nerve fibers and other tissues) within the range of the applied energy. Moreover, larger epidural electrode arrays may alter cerebral spinal fluid flow thus further altering local neural excitability states. [0012] Another challenge confronting conventional neurostimulation systems is that since epidural electrodes must apply energy across a wide variety of tissues and fluids (i.e. CSF 30 fluid amount varies along the spine as does pia mater thickness) the amount of stimulation energy needed to provide the desired amount of neurostimulation is difficult to precisely control. As such, increasing amounts of energy may be required to ensure sufficient 3 stimulation energy reaches the desired stimulation area. However, as applied stimulation energy increases so too increases the likelihood of deleterious damage or stimulation of surrounding tissue, structures or neural pathways. [00131 Improved stimulation systems and methods are desired that enable more precise and 5 effective delivery of stimulation energy. BRIEF SUMMARY OF THE INVENTION [00141 The present invention provides devices, systems and methods for simultaneously stimulating the spinal anatomy at various target locations, such as spinal levels, along the spinal cord. As described above, the spinal cord is a continuous body and may be considered 10 to include various spinal levels. For example, a spinal level may be considered a sub-section of the spinal cord wherein a dorsal root and ventral root join the spinal cord. Spinal levels may also correspond to vertebral levels of the spine commonly used to describe the vertebral bodies of the spine. [00151 The target locations are stimulated individually, in contrast to conventional SCS 15 leads which blanketly stimulate a wide area. This provides more effective treatment of pain symptoms and reduces deleterious side effects. The present invention provides devices, systems and methods for such targeted stimulation at various spinal levels. In addition, some embodiments provide additional specificity within each targeted level. [00161 In preferred embodiments, the devices, systems and methods stimulate the various 20 spinal levels at specific nerve anatomies, such as the dqrsal root DR or more specifically the dorsal root ganglion DRG. Examples described herein will illustrate specific stimulation of the dorsal root ganglia of various levels, however the embodiments are not so limited. [0017] In a first aspect of the present invention, a method is provided for stimulating a plurality of dorsal root ganglia. In some embodiments, the method comprises positioning a 25 lead within an epidural space, wherein the lead has a longitudinal axis and at least two electrodes disposed along the longitudinal axis, aligning the lead so that each of the at least two electrodes is disposed within a distance of one of the plurality of dorsal root ganglia which allows selective stimulation thereto; and electrically energizing the lead so as to provide selective stimulation to at least one of the plurality of dorsal root ganglia. In some 30 instances, electrically energizing comprises electrically energizing the lead so as to provide selective stimulation to at least two dorsal root ganglia which are not adjacent to each other. In other instances, the lead provides selective stimulation to at least two dorsal root ganglia 4 which are adjacent to each other. Various combinations of dorsal root ganglions may be stimulated simultaneously or in any pattern. [0018] In some embodiments, the at least two electrodes comprise a series of electrodes disposed along the longitudinal axis. In such embodiments, electrically energizing the lead 5 may comprise selectively energizing individual electrodes within the series of electrodes which are disposed within the distance which allows selective stimulation to the associated dorsal root ganglion. It may be appreciated that at least some distances between the individual electrodes may be irregular. [0019] In another aspect of the present invention, a telescoping lead is provided for 10 stimulation of a nerve within tissue of a body. In some embodiments, the telescoping lead comprises an elongate tubular body having a proximal end, a distal end, a lumen therethrough, and at least one electrode disposed thereon. The lead also includes an inner structure having a proximal end, a distal end, and at least one electrode disposed thereon, wherein the inner structure is advanceable through the lumen so that its distal end extends 15 beyond the distal end of the elongate tubular body, and wherein the inner structure has a strength member extending between its proximal and distal ends so as to provide sufficient strength to allow tunneling of the lead through the tissue. [0020] The tubular body and inner structure may have a variety of cross-sectional shapes. In some embodiments, the inner structure is shaped to resist rotation within the lumen. Or, 20 the tubular body may be shaped to resist rotation around the inner structure. In some instances, the tubular body has an oval or oblong shaped lumen. [00211 Typically, the at least one electrodes are substantially longitudinally aligned. However, some electrodes may be adjacent to each other or longitudually offset from each other. Optionally, the electrodes may be individually energizable. 25 [0022] In some embodiments, the inner structure is sized for advancement through a foramen. Typically the tubular body would likewise be sized for such advancement. [0023] In some embodiments, the telescoping lead further comprises an additional elongate tubular body having a proximal end, a distal end, a lumen therethrough, and at least one electrode disposed thereon. The additional elongate tubular body is configured to be 30 advanceable through the lumen of the elongate tubular body and the inner structure is 5 advanceable through the lumen of the additional elongate tubular body. Typically, the at least one electrodes are substantially longitudinally aligned. [0024] The elongate tubular body and inner structure may be positionable so that the at least one electrode on the elongate tubular body aligns with a first dorsal root ganglion while 5 the at least one electrode on the inner structure aligns with a second dorsal root ganglion. Or, the elongate tubular body and inner structure are positionable so that the at least one electrode on the elongate tubular body aligns with a first portion of a dorsal root ganglion while the at least one electrode on the inner structure aligns with a second portion of the dorsal root ganglion. 10 [0025] In another aspect of the present invention, a method is provided for stimulating at least one dorsal root ganglion. In some embodiments, the comprises advancing a telescoping lead toward a dorsal root ganglion, wherein the telescoping lead comprises an elongate tubular body having a proximal end, distal end, a lumen therethrough and at least one electrode disposed thereon, and an inner structure having at least one electrode disposed 15 thereon, wherein the inner structure is advanceable through the lumen so that its distal end extends beyond the distal end of the elongate tubular body. The method further comprises positioning at least one of the at least one electrodes near the dorsal root ganglion so as to apply stimulation to the dorsal root ganglion. [0026] In some embodiments, advancing the telescoping lead comprises advancing the 20 telescoping lead at least partially through a foramen. Advancing the telescoping lead may optionally comprise laterally approaching the dorsal root ganglion from outside of a spinal column. Or, advancing the telescoping lead may comprise advancing the telescoping lead through an epidural space. [0027] Typically, positioning comprises advancing or retracting the inner structure to 25 position at least one of the at least one electrodes disposed on the inner structure near the dorsal root ganglion. [00281 In some embodiments, positioning comprises advancing the inner structure so as to position at least one of the at least one electrodes disposed on the inner structure near the dorsal root ganglion and at least one of the at least one electrodes disposed on the tubular 30 body near another dorsal root ganglion. The dorsal root ganglion and other dorsal root ganglion may be on adjacent spinal levels. However, it may be appreciated that the dorsal root ganglion and other dorsal root ganglion may not be on adjacent spinal levels. 6 [00291 Other objects and advantages of the present invention will become apparent from the detailed description to follow, together with the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS [0030] Fig. 1A-IB, 2, 3, 4, 5 illustrate prior art. 5 [00311 Fig.6 illustrates positioning of a device of the present invention so as to optionally simultaneously stimulate various levels of the spinal cord. [0032] Fig. 7 illustrates a device extending longitudinally through the foramens of each vertebrae. [00331 Fig. 8 is a cross-sectional view of the device of Fig. 7. 10 [0034] Figs. 9A-9C illustrate embodiments of grouped lead devices that have electrodes at various spacings and/or allow adjustment of the spacing between the electrodes. [0035] Fig. 1 OA illustrates an embodiment of a grouped lead device comprising a telescoping shaft. [00361 Fig. lOB is a cross-sectional view of the device of Fig. 10A. 15 [00371 Fig. 10C is an alternative embodiment of the device of Fig. 10A having a generally circular cross-section. [00381 Fig. 11 illustrates the telescoping shaft positioned so that the electrodes are near the DRGs. [0039] Fig. 12 illustrates the stimulation of an individual DRG with a device having a 20 plurality of selectively utilizable electrodes. [0040] Fig. 13 illustrates the stimulation of an individual DRG with a device having a telescoping shaft. DETAILED DESCRIPTION OF THE INVENTION 25 [0041] Fig. 6 illustrates positioning of an embodiment of a device 200 of the present invention so as to optionally simultaneously stimulate various levels (levels 1, 2, 3 in this example) of the spinal cord S. The device 200 is shown positioned within an epidural space 7 of the spinal column at a lateral distance from the midline M of the of the spinal column which aligns the device 200 with the dorsal root ganglions DRG 1, DRG 2, DRG 3. Thus, portions of the device 220 align with and may optionally contact the dorsal root ganglions DRG 1, DRG 2, DRG 3, as indicated by shading. These aligned portions provide targeted or 5 selective stimulation of one or more of the dorsal root ganglions DRG 1, DRG 2, DRG 3 while avoiding or reducing stimulation to surrounding tissues, such as the ventral roots VR1, VR2, VR3. [0042] The device 200 is electrically connected to a power source or implantable pulse generator (IPG) 202, as shown, which is implanted in the body of the patient. Fig. 6 10 illustrates antegrade positioning of the device 200, however a retrograde approach may also be used.. Thus, the device 200 extends across multiple levels in the form of a grouped lead providing a single extension to the IPG 202, or any number of extensions which is less than the number of targeted levels. [00431 Fig. 7 provides a side view of the spinal cord S including the bony structures or 15 vertebrae V which surround and protect the spinal cord S. The device 200 is shown extending longitudinally through the foramens of each vertebrae V. Optionally, the device 200 may be anchored to a vertebrae V with the use of an anchoring device 204, such as a bone screw or bone tack as shown, to resist migration. Fig. 8 provides a cross-sectional view of the device 200 of Fig. 7 showing the device 200 positioned against a DRG. It may be 20 appreciated that the device 200 may be positioned at a variety of locations adjacent or near the DRG while maintaining the longitudinal orientation. [00441 Figs. 9A-9C illustrate embodiments of devices 200 of the present invention that have electrodes 210 at various spacings and/or allow adjustment of the spacing between activated electrodes. Fig. 9A illustrates an embodiment of a device 200 comprising an 25 elongate body 201 having at least two electrodes 210 disposed thereon. The elongate body 201 has a longitudinal axis 203, and in this embodiment, the at least two electrodes 210 are disposed along the longitudinal axis 203. The at least two electrodes 210 have a fixed spacing along the longitudinal axis 203 according to the distance between spinal levels or the longitudinal distance between DRGs along the spinal column (based on the average patient 30 population or based on specific anatomies). Distances X & Y illustrate the distances between the at least two electrodes 210. Distances X & Y may be the same or different from each other. The distances are such that each electrode 210 is within range of a target DRG, when 8 the device 200 is aligned according to Fig. 6, and each electrode 210 is disposed within a distance which allows selective stimulation thereto. [0045] Fig. 9B illustrates an embodiment of a device 200 comprising an elongate body 201 having a plurality of electrodes 210 disposed thereon. The electrodes 210 are positioned so 5 that two or more electrodes 210 grouped at spaced distances. For example, Fig. 9B illustrates a first group of electrodes 21 Oa disposed near a distal end of the elongate body 201, a second group of electrodes 21 Ob disposed midway along the elongate body 201, and a third group of electrodes 21 Oc disposed near a proximal end of the elongate body 201. In this example, each group 21 Oa, 21 Ob, 21 Oc includes three electrodes disposed along the longitudinal axis 10 203. When the elongate body 201 is positioned within the anatomy, slight anatomical variations in distance between DRGs may occur. Therefore, the electrode 210 within each group 21 0a, 21 Ob, 21 Oc that aligns most closely with the target DRG of that group or that provides the most desirable therapeutic effects may be utilized (as indicated by shading). The remaining two electrodes in the group will not receive stimulating energy. It may be 15 appreciated that in some embodiments, more than one electrode 210 may be used within each group if such use provides a more desirable result. The distances X & Y between the stimulating electrodes can thus be varied to accommodate differences in DRG spacing for individual patients. Further, if by chance the device 200 migrates over time or is otherwise performing less than optimally, the electrodes 210 which receive stimulation energy can be 20 changed without altering the position of the elongate body 201. Thus, the DRGs can be retargeted by modifying the distances X & Y. [0046] Fig. 9C also illustrates an embodiment of a device 200 comprising an elongate body 201 having a plurality of electrodes 210 disposed thereon along a longitudinal axis 203. In this embodiment, the electrodes 210 are positioned substantially continuously along the 25 device 200. Electrodes are selectively utilized (as indicated by shading) to adjust X & Y to accommodate differences in DRG spacing for individual patients. Any number of electrodes may be present in any arrangement. Also, any number of spaced distances may be present, such as to create distances such as X & Y & Z, etc. [00471 Figs. 10A-10C illustrate an embodiment of a grouped lead device 200 comprising a 30 telescoping shaft 220 which allows adjustable positioning of the electrodes 210. In this embodiment, the telescoping shaft 220 comprises a first structure or elongate tubular body 220a and a second structure or elongate tubular body 220b. Each tubular body 220a, 220b 9 has a proximal end, a distal end and a lumen therethrough. Each tubular body 220a, 220b also includes at least one electrode disposed thereon, typically near its distal end. In this embodiment, the second elongate tubular body is advanceable through the lumen of the first elongate tubular body 220a so that its distal end, and electrode 210 disposed thereon, extends 5 beyond the distal end of the first elongate tubular body 220a. The shaft 220 also includes an inner structure 220c having a distal end and, wherein the inner structure is advanceable through the lumen of the second tubular body 220b so that its distal end extends beyond the distal end of the second elongate tubular body 220b. The inner structure 220c also has at least one electrode 210 disposed thereon, so that the electrode 210 is exposed beyond the 10 distal end of the second elongate tubular body 220b. Thus, all three electrodes 210 may be simultaneously exposed and utilized for stimulating tissue. The distances X & Y between the electrodes 210 can be adjusted by moving the tubular bodies 220a, 220b and inner structure 220c relative to each other, such as by extension and retraction. [0048] The telescoping structures 220a, 220b, 220c may be comprised of various materials, 15 preferably a flexible polymer. In some embodiments, the inner structure 220c has a strength member extending between its proximal and distal ends so as to provide sufficient strength to allow tunneling of the device 200. Optionally, the structures 220a, 220b, 220c may be supported by a stylet during placement. The telescoping structures 220a, 220b, 220c may have various cross-sectional shapes, including shapes that resist rotation. Fig. 10B illustrates 20 an example of a rotation resisting shape, a flat shape which may be oval or oblong, rectangular, polygonal, etc. The flatness of the shape resists rotation of, for example, the inner structure 220c within the second tubular body 220b or the second tubular body 220b within the first tubular body 220a. Such resistance rotation ensures that the electrodes maintain rotational orientation to each other, such as longitudinal alignment. Alternatively, 25 the cross-sectional shape may be thick (Fig. 1 OC) which may be circular, square, rectangular, polygonal, etc. When the shape is circular, the rotational orientation of the electrodes can be adjusted. [0049] Electrodes 210 may be easier to attach to flat designs, conserve energy, etc. Flat designs may also provide easier determination of orientation of the electrodes 210, as 30 describe above, during delivery and implantation. The cross-sectional shape may also be chosen based on location in anatomy where the device is to be placed. Fig. 11 illustrates the telescoping shaft 220 positioned within the epidural space so that the electrodes 210 are near DRGs on multiple spinal levels. This may be achieved by advancing or retracting the 10 telescoping structures 220a, 220b, 220c so that the electrodes 210 substantially align with the DRGs. Conductive wires electrically connected to the electrodes 210 extend out the proximal end to an IPG. [0050] The above embodiments describe devices, systems and methods that directly 5 stimulate the dorsal root, particularly the dorsal root ganglion (DRG), while minimizing or excluding undesired stimulation of other anatomies. In some embodiments, this allows access to multiple levels of the spinal column with the use of a single device. This reduces procedure complexity, time and recovery since a single access path is created rather than individual access paths to each level of the spinal column. These embodiments also have a 10 reduced number of paths to an IPG. It may be appreciated that the devices, systems and methods of the present invention may also be used to stimulate other portions of the spinal anatomy or other anatomies. [00511 It may also be appreciated that the devices and systems of the present invention may also be used to stimulate a single DRG. For example, Fig. 12 illustrates a device 200 such as 15 or similar to the device of Fig. 9C wherein the device 200 comprises an elongate body 201 having a plurality of electrodes 210 disposed substantially continuously thereon along a longitudinal axis 203. The device 200 is advanced through the epidural space and at least a portion of the device 200 is advanced laterally toward a single DRG. In some instances, this includes advancement through a foramen. The device 200 is positioned so that at least one of 20 the plurality of electrodes 210 is disposed on, near or about the DRG. The electrodes are then selectively utilized (as indicated by shading) so that the electrode(s) 210 which provide the most desirable result receive stimulation energy. The remaining electrodes receive a lower level or no stimulation energy. [0052] Similarly, Fig. 13 illustrates a device 200 having a telescoping shaft 220 such as or 25 similar to that of Fig. 10A. Again, the telescoping shaft 220 comprises a first structure or elongate tubular body 220a and a second structure or elongate tubular body 220b. Each tubular body 220a, 220b has a proximal end, a distal end and a lumen therethrough. Each tubular body 220a, 220b also includes at least one electrode disposed thereon, typically near its distal end. In this embodiment, the second elongate tubular body is advanceable through 30 the lumen of the first elongate tubular body 220a so that its distal end, and electrode 210 disposed thereon, extends beyond the distal end of the first elongate tubular body 220a. The shaft 220 also includes an inner structure 220c having a distal end and, wherein the inner 11 structure is advanceable through the lumen of the second tubular body 220b so that its distal end extends beyond the distal end of the second elongate tubular body 220b. The inner structure 220c also has at least one electrode 210 disposed thereon, so that the electrode 210 is exposed beyond the distal end of the second elongate tubular body 220b. Thus, all three 5 electrodes 210 may be simultaneously exposed and utilized for stimulating tissue. [0053] Fig. 13 shows the device 200 laterally approaching an individual DRG from outside of a spinal column. One or more of the first tubular body 220a, second tubular body 220b and inner structure 220c may be advanced or retracted so that at least one electrode 210 is disposed on, near or about the DRG. The electrodes are then selectively utilized (as indicated 0 by shading) so that the electrode(s) 210 which provide the most desirable result receive stimulation energy. The remaining electrodes receive a lower level or no stimulation energy. [0054] Although the foregoing invention has been described in some detail by way of illustration and example, for purposes of clarity of understanding, it will be obvious that various alternatives, modifications and equivalents may be used and the above description 5 should not be taken as limiting in scope of the invention. [0055] Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" and "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or 0 steps. [0056] The reference to any prior art in this specification is not, and should not be taken as, an acknowledgement or any form of suggestion that the prior art forms part of the common general knowledge in Australia. 12

Claims (13)

1. A lead for stimulating nerve anatomy comprising: an elongate body having at least one first electrode disposed thereon and at least one second electrode longitudinally aligned a longitudinal distance from the at least one first electrode, wherein the longitudinal distance provides for the at least one first electrode to be positioned on, near or about a dorsal root ganglion so as to provide selective stimulation thereto while the at least one second electrode is positioned outside of a spinal nerve root associated with the dorsal root ganglion.
2. A lead as in claim 1, wherein the longitudinal distance provides for the at least one first electrode to be positioned on, near or about the dorsal root ganglion so as to provide selective stimulation thereto while the at least one second electrode is positioned along a peripheral nerve beyond a mixing point of a dorsal root and a ventral root associated with the dorsal root ganglion.
3. A lead as in claim 1, wherein the longitudinal distance provides for the at least one first electrode to be positioned on, near or about the dorsal root ganglion so as to provide selective stimulation thereto while the at least one second electrode is positioned along a spinal cord.
4. A lead as in any of the above claims, wherein the at least one first electrode comprises a plurality of first electrodes and further comprising an implantable pulse generator connectable with the lead so as to provide stimulation energy to a selection of the plurality of first electrodes which provides the most desirable result of selectively stimulating the dorsal root ganglion.
5. A lead as in any of the above claims, wherein the longitudinal distance is adjustable by energizing different electrodes.
6. A lead as in any of claims 1-4, wherein the longitudinal distance is adjustable by physically moving at least some of the electrodes in relation to each other.
7. A lead as in any of the above claims, wherein the electrodes are individually energizeable.
8. A lead as in any of the above claims, wherein the elongate body is configured for advancement through an epidural space.
9. A lead as in any of the above claims, wherein the elongate body is configured for advancement laterally toward the dorsal root ganglion.
10. A lead as in any of the above claims, wherein the elongate body is configured for advancement through a foramen.
11. A lead as in claim 1, wherein the longitudinal distance provides for the at least one first electrode to be positioned on, near or about the dorsal root ganglion so as to provide selective stimulation thereto while the at least one second electrode is positioned on, near or about another dorsal root ganglion.
12. A lead as in claim 1, wherein the elongate body comprises an elongate tubular body having the at least one first electrode disposed thereon, and an inner structure having the at least one second electrode disposed thereon, wherein the inner structure is advanceable through the elongate tubular body so as to adjust the longitudinal distance between the at least one first electrode and the at least one second electrode.
13. A lead as in claim 1, wherein the elongate body comprises an elongate tubular body having the at least one second electrode disposed thereon, and an inner structure having the at least one first electrode disposed thereon, wherein the inner structure is advanceable through the elongate tubular body so as to adjust the longitudinal distance between the at least one first electrode and the at least one second electrode.
AU2014202705A 2006-12-06 2014-05-19 Grouped leads for spinal stimulation Active AU2014202705B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US60/873,464 2006-12-06
AU2012203467A AU2012203467B2 (en) 2006-12-06 2012-06-14 Grouped leads for spinal stimulation
AU2014202705A AU2014202705B2 (en) 2006-12-06 2014-05-19 Grouped leads for spinal stimulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2014202705A AU2014202705B2 (en) 2006-12-06 2014-05-19 Grouped leads for spinal stimulation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2012203467A Division AU2012203467B2 (en) 2006-12-06 2012-06-14 Grouped leads for spinal stimulation

Publications (2)

Publication Number Publication Date
AU2014202705A1 AU2014202705A1 (en) 2014-06-19
AU2014202705B2 true AU2014202705B2 (en) 2015-09-03

Family

ID=51059717

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014202705A Active AU2014202705B2 (en) 2006-12-06 2014-05-19 Grouped leads for spinal stimulation

Country Status (1)

Country Link
AU (1) AU2014202705B2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6104957A (en) * 1998-08-21 2000-08-15 Alo; Kenneth M. Epidural nerve root stimulation with lead placement method
US20010053885A1 (en) * 1998-04-30 2001-12-20 Frans Gielen Techniques for positioning therapy delivery elements within a spinal cord or a brain
US20050209655A1 (en) * 2002-02-04 2005-09-22 Kerry Bradley Method for optimizing search for spinal cord stimulation parameter settings

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010053885A1 (en) * 1998-04-30 2001-12-20 Frans Gielen Techniques for positioning therapy delivery elements within a spinal cord or a brain
US6104957A (en) * 1998-08-21 2000-08-15 Alo; Kenneth M. Epidural nerve root stimulation with lead placement method
US20050209655A1 (en) * 2002-02-04 2005-09-22 Kerry Bradley Method for optimizing search for spinal cord stimulation parameter settings

Also Published As

Publication number Publication date
AU2014202705A1 (en) 2014-06-19

Similar Documents

Publication Publication Date Title
US7613524B2 (en) Winged electrode body for spinal cord stimulation
EP2586488B1 (en) Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems
EP2853285B1 (en) Multi-frequency neural treatments and associated systems
US8812131B2 (en) Current steering for an implantable stimulator device involving fractionalized stimulation pulses
EP2421600B1 (en) Spinal cord modulation systems for inducing paresthetic and anesthetic effects
JP5643764B2 (en) Selective stimulation system and medical condition signal parameters
US8332046B2 (en) Neural interface system
AU726391B2 (en) High resolution brain stimulation lead and method of use
US20080103572A1 (en) Implantable medical lead with threaded fixation
US7715924B2 (en) Adjustable simulation device and method of using same
CN101048194B (en) Neurostimulation methods and systems
JP2012521801A (en) Management of pain with subthreshold stimuli for illusion
US9333339B2 (en) Peripheral nerve stimulation
AU2016202589B2 (en) Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9713706B2 (en) Implantable medical elongated member including intermediate fixation
Slavin Peripheral nerve stimulation for neuropathic pain
US8588914B2 (en) Implantable medical device with electrodes on multiple housing surfaces
US20070168008A1 (en) Implantable Medical Electrical Leads, Kits, Systems and Methods of Use Thereof
US8019441B2 (en) Collapsible/expandable tubular electrode leads
US5713922A (en) Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain
US20050203602A1 (en) Collapsible/expandable electrode leads
US7848818B2 (en) System and method for neurological stimulation of peripheral nerves to treat low back pain
JP5922817B2 (en) Methods, systems, and devices for neuromodulating spinal cord tissue
US20100016929A1 (en) Method and system for controlled nerve ablation
US8452417B2 (en) System and method for treating pain with peripheral and spinal neuromodulation

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)